Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.

D. Rasmussen (Naestved, Denmark), U. Bodtger (Naestved, Denmark), M. Lamberts (Hellerup, Denmark), P. Lange (Copenhagen, Denmark), M. Jensen (Hellerup, Denmark)

Source: International Congress 2019 – More and more COPD
Session: More and more COPD
Session type: Thematic Poster
Number: 4425
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Rasmussen (Naestved, Denmark), U. Bodtger (Naestved, Denmark), M. Lamberts (Hellerup, Denmark), P. Lange (Copenhagen, Denmark), M. Jensen (Hellerup, Denmark). Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.. 4425

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019


High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction
Source: Eur Respir J 2005; 26: Suppl. 49, 218s
Year: 2005

The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018



Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury
Source: Eur Respir J, 49 (6) 1700096; 10.1183/13993003.00096-2017
Year: 2017



Acute myocardial infarction in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017



Passive smoking and risk of fatal and non-fatal myocardial infarction in a cohort of Danish workers
Source: Annual Congress 2008 - Environmental tobacco smoke and smoking ban
Year: 2008


Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Identification of risk factors of acute cardiovascular events in acute exacerbation period for patients with COPD: a prospective nested case-control study
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Exacerbation frequency and increased risk of myocardial infarction in COPD
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD
Source: Eur Respir J 2005; 25: 634-639
Year: 2005



Pattern of risk of myocardial infarction (MI) in patients taking asthma medication: a study with the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


COPD in patients evaluated for stable myocardial ischemia – observational study
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland
Source: Eur Respir J, 51 (3) 1701794; 10.1183/13993003.01794-2017
Year: 2018



One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006

Use of heart failure medications in outpatients with COPD and congestive heart failure: a Danish nationwide cohort study
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017

Acute myocardial infarction among Spanish adults with and without COPD: Cumulative incidence and outcomes
Source: International Congress 2014 – COPD markers
Year: 2014